Vulvovaginal atrophy: current methods of diagnosis and treatment

被引:0
|
作者
Zainetdinova, L. F. [1 ]
Telesheva, L. F. [2 ]
Medvedev, B. I. [1 ]
V. Khakhulina, V. [1 ]
机构
[1] South Ural State Med Univ, Dept Obstet & Gynecol, 64 Vorovskogo Str, Chelyabinsk 454092, Russia
[2] South Ural State Med Univ, Dept Microbiol, Virol, Immunol, 64 Vorovskogo Str, Chelyabinsk 454092, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2024年 / 23卷 / 01期
关键词
vulvovaginal atrophy; genitourinary syndrome of menopause; peri- and postmenopause; QUALITY-OF-LIFE; GENITOURINARY SYNDROME; POSTMENOPAUSAL WOMEN; SEXUAL DYSFUNCTION; SYMPTOMS; MENOPAUSE; OZONE; PREVALENCE; THERAPY; IMPACT;
D O I
10.20538/1682-0363-2024-1-134-143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To review modern methods of diagnosis and treatment of vulvovaginal atrophy (VVA), which is one of the manifestations of genitourinary syndrome of menopause in peri- and postmenopausal women. Materials and methods. A review of domestic and foreign literature on the prevalence and modern methods of diagnosis and treatment of VVA was carried out. Results. Unlike vasomotor symptoms, VVA progresses with age, causing a significant impairment in women's quality of life. Symptoms usually begin to bother perimenopausal patients, but their frequency and severity increase significantly in postmenopausal women. Diagnosis of VVA can present some difficulties, as many women perceive their condition as a natural manifestation of aging and do not seek medical care. Currently, drug and non-drug therapies for VVA have been proposed, each of which has its own characteristics, indications, and contraindications. However, the safety and effectiveness of some of them have not been fully proven. Conclusion. VVA is common in peri- and postmenopausal women. Modern aspects of the diagnosis and treatment of this pathology can significantly improve the quality of life of patients with VVA symptoms. However, further research is needed to confirm safety of the proposed treatment methods, and search for new techniques is required.
引用
收藏
页数:179
相关论文
共 50 条
  • [1] Treatment of Vulvovaginal Atrophy
    Crandall, Carolyn J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (19): : 1910 - 1911
  • [2] Ospemifene in the Treatment of Vulvovaginal Atrophy
    Barnes, Kylie N.
    Pearce, Erica F.
    Yancey, Abigail M.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) : 752 - 757
  • [3] Sequential treatment in vulvovaginal atrophy
    Palacios, Santiago
    CLIMACTERIC, 2023, 26 (04) : 292 - 295
  • [4] Prevalence, Etiology & Diagnosis of Vulvovaginal Atrophy
    Freedman, Murray A.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (12): : 1338 - 1339
  • [5] Endocrine treatment of vulvovaginal atrophy
    Bausewein, Lucia
    Schueler-Toprak, Susanne
    Ortmann, Olaf
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2024, 22 (02): : 135 - 142
  • [6] Post-menopausal vulvovaginal atrophy - an overview of the current treatment options
    Szymanski, Jacek Krzysztof
    Siekierski, Bogumil Pawel
    Kajdy, Anna
    Jakiel, Grzegorz
    GINEKOLOGIA POLSKA, 2018, 89 (01) : 40 - 47
  • [7] Vulvovaginal Atrophy Following Treatment for Oncogynecologic Pathologies: Etiology, Epidemiology, Diagnosis, and Treatment Options
    Narutyte, Ramune
    Zukiene, Guoda
    Bartkeviciene, Daiva
    MEDICINA-LITHUANIA, 2024, 60 (10):
  • [8] Vulvovaginal Atrophy: Current and Future Therapies (CME)
    Ibe, Comfort
    Simon, James A.
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (03): : 1042 - 1050
  • [9] Vulvovaginal Atrophy
    Mac Bride, Maire B.
    Rhodes, Deborah J.
    Shuster, Lynne T.
    MAYO CLINIC PROCEEDINGS, 2010, 85 (01) : 87 - 94
  • [10] Response to: A new approach to treatment of vulvovaginal atrophy
    Kim, Tae-Hee
    Lee, Hae-Hyeog
    Kim, Jun-Mo
    MATURITAS, 2015, 81 (01) : 100 - 100